Question

I am a breastfeeding mother and i want to know if it is safe to use NSC 752? Is NSC 752 safe for nursing mother and child? Does NSC 752 extracts into breast milk? Does NSC 752 has any long term or short term side effects on infants? Can NSC 752 influence milk supply or can NSC 752 decrease milk supply in lactating mothers?

NSC 752 lactation summary

NSC 752 is dangerous in breastfeeding
  • DrLact safety Score for NSC 752 is 7 out of 8 which is considered Dangerous as per our analyses.
  • A safety Score of 7 indicates that usage of NSC 752 may cause toxic or severe side effects in breastfed baby.
  • Our study of different scientific research indicates that NSC 752 may cause moderate to high side effects or may affect milk supply in lactating mother.
  • Our suggestion is to use safer alternate options rather than using NSC 752 .
  • Usage of NSC 752 is in contradiction to breastfeeding hence if it is must to use NSC 752 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About NSC 752 usage in lactation

Indicated for treatment of leukemia.

Answer by DrLact: About NSC 752 usage in lactation

Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, although antimetabolites such as NSC 752 appear to pose the least risk to breastfed infants.[1] NSC 752 levels in milk are reportedly low. NSC 752 nucleosides are active intracellular metabolites of azathioprine and have been measured in breastmilk and in infant serum following maternal use of azathioprine as an immunosuppressant. Although amounts in milk were low in breastmilk and mostly undetectable in infant serum, relatively low dosages of azathioprine were used. After high-dose chemotherapy, it might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence. Although no data are available to determine an appropriate period to withhold breastfeeding, the drug's terminal half-life suggests that withholding breastfeeding for 4 days may be sufficient. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk.[2]

NSC 752 Side Effects in Breastfeeding

NSC 752 is an active metabolite of azathioprine. Numerous infants breastfed during maternal azathioprine in dosages up to 250 mg daily have been reported with no adverse effects noted. See Azathioprine record for details.

Alternate Drugs

Fluorouracil(Dangerous)
Capecitabine(Dangerous)
Gemcitabine(Dangerous)
Thioguanine(Dangerous)
Dasatinib(Unsafe)
Docetaxel(Dangerous)
Nilotinib(Unsafe)
Ipilimumab(Unsafe)
Vincristine(Dangerous)
Cetuximab(Unsafe)
Tamoxifen(Dangerous)
Carboplatin(Dangerous)
Mitoxantrone(Dangerous)
Paclitaxel(Dangerous)
Letrozole(Dangerous)
Fluorouracil(Dangerous)
Exemestane(Dangerous)
Nivolumab(Unsafe)
Dactinomycin(Dangerous)
Vinblastine(Dangerous)
Alemtuzumab(Low Risk)
Bleomycin(Dangerous)
Hydroxyurea(Low Risk)
Rituximab(Low Risk)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Etoposide(Dangerous)
Dacarbazine(Dangerous)
Doxorubicin(Dangerous)
Bevacizumab(Low Risk)
Gemcitabine(Dangerous)
Cyclophosphamide(Dangerous)
Thioguanine(Dangerous)
Cisplatin(Unsafe)
Erlotinib(Unsafe)
Busulfan(Dangerous)
Cladribine(Dangerous)
Trastuzumab(Unsafe)
Imatinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.